drugset / Trial / NCT07437079

A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity

NCT07437079 ↗

Phase 1 Recruiting 96 enrolled Novo Nordisk A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is testing a new medicine, NNC6989-0001, to test it is safe and tolerable for healthy people living with overweight or obesity. NNC6989-0001 is still being tested in studies and is not yet available for prescription by doctors. In this study, participants will receive either NNC6989-0001 or a placebo; which treatment each participant receives will be decided by chance.

Timeline

Start
2026-02-24
Primary completion
2027-01-21
Completion
2027-01-21

Drugs

EvaluationDrugModalityDoseRoute
Subject NNC6989-0001 Unknown — —

Indications